Do Gender and Race/Ethnicity Influence Acute Myocardial Infarction Quality of Care in a Hospital with a Large Hispanic Patient and Provider Representation?

Table 2

Selected outcomes in patients admitted with a suspected (𝑛=463) and confirmed (𝑛=387) Acute Myocardial Infarction according to gender and race ethnicity.

	Men		Women		P value	Hispanics		Non-Hispanic whites		P value
	𝑁 (or M)	% (or SD)	𝑁 (or M)	% (or SD)		𝑁 (or M)	% (or SD)	𝑁 (or M)	% (or SD)
Suspected AMI (𝑛=463)
Death	16	7.3	10	4.1	0.129	15	5.2	11	6.3	0.22
Confirmed AMI	212	97.2	175	71.4	<0.001	229	79.8	158	89.8	0.005
Stress testing	10	4.6	54	22	<0.001	43	15.0	21	11.9	0.36
CATH	152	69.7	126	51.4	<0.001	171	59.6	107	60.8	0.79
PCI	80	36.7	54	22	<0.001	82	28.6	52	29.5	0.82
CABG	49	22.5	25	10.2	<0.001	50	17.4	24	13.6	0.28
Confirmed AMI (𝑛=387)
Death	16	7.5	10	5.7	0.47	15	6.6	11	7	0.87
STEMI	77	36.3	33	18.9	<0.001	59	25.8	51	32.3	0.167
CATH	147	69.3	110	62.9	0.179	154	67.2	103	65.2	0.67
PCI	78	36.8	52	29.7	0.142	78	34.1	52	32.9	0.81
CABG	46	21.7	24	13.7	0.042	47	20.5	23	14.6	0.134
ASA (Hosp)	193	93.7	126	92.1	0.566	185	93.0	136	93.2	0.95
Beta blockers (Hosp)	182	88.3	119	85.6	0.46	175	87.9	126	86.3	0.65
ACEI/ARB (Hosp)	130	63.1	91	65.5	0.65	125	62.8	96	65.8	0.57
Statins/Antilipidemics (Hosp)	154	75.5	104	74.8	0.89	146	73.7	112	77.2	0.46
Clopidogrel (Hosp)	108	52.4	71	51.1	0.81	104	52.3	75	51.4	0.87
ASA (DC)	165	87.3	119	88.1	0.82	165	88.7	119	86.2	0.50
Beta Blockers (DC)	149	78.4	102	75.6	0.54	148	79.1	103	74.6	0.34
ACEI/ARB (DC)	94	50	74	55.2	0.36	95	51.6	73	52.9	0.82
Statins/Antilipidemics (DC)	135	71.4	96	71.1	0.95	135	72.6	96	69.6	0.55
Clopidogrel (DC)	100	53.2	67	49.6	0.53	95	51.1	72	52.6	0.79
Composite medications index	104	75.96	150	76.00	0.96	146	76.2	107	75.73	0.924

AMI: acute myocardial infarction; CATH: cardiac catheterization; PCI: percutaneous coronary intervention; CABG: coronary artery bypass graft; STEMI: ST segment elevation myocardial infarction; ASA: aspirin; Hosp: prescribed on admission; ACEI/ARB: angiotensin converting enzyme inhibitor/Angiotensin receptor blocker; DC: prescribed at discharge.